Back to Horizon Kinetics Asset Management LLC Horizon Kinetics Asset Management LLC

NTLANTLA

Showing 8 of 25 quarters

Position history for Horizon Kinetics Asset Management LLCHorizon Kinetics Asset Management LLC's holdings in Intellia Therapeutics, Inc.

Yes. Horizon Kinetics Asset Management holds 12,584 shares of NTLA (Intellia Therapeutics), worth $212,921, as of its Q2 2026 13F filing. It reduced the position by 604 shares (-4.6%) from Q1 2026. Horizon Kinetics Asset Management has held NTLA since Q2 2020, across 25 quarterly 13F filings.

Current Value

$212,921

Current Shares

12,584

Total Value Change

-$70,505

Total Shares Change

-1,208

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
12,584
-4.6%
$212,9210.0%$16.92
0
2026-Q1
Decreased
13,188
-4.4%
$169,0700.0%$12.82
0
2025-Q4
Decreased
13,792
-4.2%
$123,9900.0%$8.99
0
2025-Q3
Increased
14,396
+4.4%
$248,6190.0%$17.27
24
2025-Q2
Decreased
13,792
-5.5%
$129,3690.0%$9.38
0
2025-Q1
Increased
14,596
+1.4%
$103,7780.0%$7.11
22
2024-Q4
Increased
14,396
+4.4%
$167,8570.0%$11.66
24
2024-Q3
Decreased
13,792
-4.2%
$283,4260.0%$20.55
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used